World

French minister calls for new EU medical agency for vaccine research

June 17, 2021
French Minister for Industry Agnès Pannier-Runacher has called for the creation of a pan-European agency that would fund research into vaccines. — Courtesy file photo
French Minister for Industry Agnès Pannier-Runacher has called for the creation of a pan-European agency that would fund research into vaccines. — Courtesy file photo

BRUSSELS — French Minister for Industry Agnès Pannier-Runacher has called for the creation of a pan-European agency that would fund research into vaccines.

Speaking to Euronews Next at the VivaTech 2021 conference in Paris, Pannier-Runacher said America's rapid vaccine rollout had demonstrated the effectiveness of the United States' Biomedical Advanced Research and Development Authority (BARDA).

She added that Europe should follow its example.

"We need to be at the level of Europe because France only is not so interesting. It's only 67 million people. Europe, it's 450 million people. So, it's a huge market," she said.

"You can have direct discussions with companies who develop innovations, R&D, and in the case of a pandemic, vaccination or treatment. And this is something that we support as a government at the European level, the equivalent of a BARDA".

A US government agency, BARDA funds research and production of treatments — like COVID vaccines — considered to be priorities for national health security.

In February last year, it partnered with French drugmaker Sanofi to fund work on an as-yet unreleased coronavirus vaccine.

Pannier-Runacher also told Euronews that European governments should support biomedical development by transferring the rights to research and technology to private companies.

"I believe we have the right level of academics at the level of researchers, universities, teams. It's rather good. What we need is to accelerate technology transfers to companies and to those companies to develop quickly," she said.

The minister said she believed European governments also needed to do more to encourage private capital to invest in biomedical research on the continent.

"In the United States, you can increase capital quite easily. In France and in Europe, it's more difficult to find the venture capital and the experts to assess the quality of your projects, to trust you, to put cash in it and to develop the business," Pannier-Runacher said

"I believe that the French tech is now really a success and the government has supported the French tech for ten years now. And this is a huge success. But the key question is scaling up." — Euronews


June 17, 2021
135 views
HIGHLIGHTS
World
2 hours ago

Biden keeps needling Trump as he walks a tightrope over his rival’s trial

World
2 hours ago

Hersh Goldberg-Polin: Gaza hostage's parents urge him to 'stay strong' after new video

World
2 hours ago

Searing heat shuts schools for 33 million children